FBRX vs NSC · $360.2M cap vs P/E 18, rev $6.46B
Forte Biosciences Inc (FBRX) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Forte Biosciences Inc (FBRX) is a biotechnology company listed on NASDAQ.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
FBRX does not have a complete income-statement cache yet.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
FBRX currently screens at market cap $360.2M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the FBRX and NSC stock pages for the full models.
Not investment advice.